Lina Merjaneh, MD

Personal Statement

I am a board-certified pediatric endocrinology and diabetes specialist. I am deeply committed to providing high-quality, evidence-based and compassionate care to my patients and their families. I always aim to collaborate with patients and families to help them personalize and achieve their health care goals.

Clinical Interests

Cystic fibrosis-related diabetes and endocrine disorders, type 1 and type 2 diabetes, disorders of growth and puberty, genetic syndromes, general endocrinology

Education

* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.

Research interests

1) Understanding cystic fibrosis-related diabetes and the role that hyperglycemia plays in cystic fibrosis pulmonary exacerbations, with the ultimate goal of improving the life and outcomes of people with cystic fibrosis; 2) Type 1 and type 2 diabetes, particularly around factors affecting diabetes outcomes including barriers to care

Merjaneh L, Sidhaye AR, Vu PT, Heltshe SL, Goss CH, Flume PA, Kelly A, Rosenfeld M on behalf of the STOP2 investigators. Role of hyperglycemia in cystic fibrosis pulmonary exacerbations. Journal of Cystic Fibrosis, 2023 Jun 30:S1569-1993(23)00825-1. doi: 10.1016/j.jcf.2023.06.011. Epub ahead of print. PMID: 37394317

Merjaneh L, Dolan LM, Suerken CK, D'Agostino R Jr, Imperatore G, Saydah S, Roberts A, Marcovina S, Mayer-Davis EJ, Dabelea D, Lawrence JM, Pihoker C. A longitudinal assessment of diabetes autoantibodies in the SEARCH for diabetes in youth study. Pediatric Diabetes, 2022 Nov;23(7):1027-1037. doi: 10.1111/pedi.13403. Epub 2022 Aug 30. PMID: 36054435

Merjaneh L, Hasan S, Kasim N, Ode KL. The role of modulators in cystic fibrosis related diabetes. Journal of Clinical and Translational Endocrinology, 2021 Dec 7;27:100286. doi: 10.1016/j.jcte.2021.100286. PMID: 34917484; PMCID: PMC8668978

Merjaneh L, Toprak D, McNamara S, Nay L, Sullivan E, Rosenfeld M. Acute Hyperglycemia in Cystic Fibrosis Pulmonary Exacerbations. Endocrinology, Diabetes & Metabolism, 2020;00:e00208

Merjaneh L, Pihoker P, Fino N, Divers J, Klingensmith G, Shrestha S, Saydah S, Mayer-Davis E, Dabelea D, Powell J, Lawrence J, Dolan L, Linder B, Wright D. Out of Pocket Medical Expenses for Children and Young Adults with Diabetes: The SEARCH for Diabetes in Youth Cohort Study. Diabetes Care, 2019 Nov; 42(11): e172-e174. PMID: 31530657. PMCID: PMC6804608

Merjaneh L, He Q, Long Q, Philips LS, Stecenko A. Disposition index identifies defective beta cell function in cystic fibrosis subjects with normal glucose tolerance. Journal of Cystic Fibrosis, 2015 Jan;14(1):135-41. PMID: 24998161

Merjaneh L, Muir A, Parks JS, Fadoju D. A novel TRPS1 gene mutation causing trichorhinophalangeal syndrome with growth hormone responsive short stature: a case report and review of the literature. International Journal of Pediatric Endocrinology, 2014;2014(1):16. PMID: 25177352. PMCID: PMC4148676

View PubMed Publications